More than 145 European hematopoietic SCT programs have received JACIE (Joint Accreditation Committee for ISCT Europe and EBMT) accreditation since 2000, demonstrating compliance with FACT (Foundation ...

Allogeneic SCT was introduced in the treatment of multiple myeloma (MM) 25 years ago, yet its role remains controversial. Although allogeneic SCT is possibly the only curative treatment and can induce ...

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities In this retrospective study ...